🔥🔥🔥 JOIN OUR STARTUP AMBASSADOR PROGRAM 🔥🔥🔥
    📣 Spread the news & get a PRO membership 3 months for FREE with all features🚀📈💵500 vouchers left • 3 months free

    Juvenescence

    Juvenescence is a clinical-stage drug development company that creates small molecules, biologics, and cell therapies designed to target core aging mechanisms. The company focuses on early disease intervention and prevention to treat age-related conditions and extend human healthspan. Its research and development process integrates AI and data science tools to design novel compounds and manage adaptive clinical trials.

    Visit websiteRamsey, UK
    Biotechnology
    Pharmaceuticals
    Life Sciences
    Longevity
    Healthtech

    Funding summary

    Total raised
    €66.7M
    Funding rounds
    1

    Investors in Juvenescence

    Investors on record for Juvenescence. Click any investor to view their CAPLINK profile and funding criteria.

    Fundraising for a startup like Juvenescence?

    Explore CAPLINK's investor database of thousands of active VCs and angels.

    Browse investors

    We use cookies to enhance your experience. Read our Privacy Policy